ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 100 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | -97.1% | 2,000 | -93.8% | 0.00% | -98.5% |
| Q3 2021 | $104,000 | +593.3% | 32,000 | +357.1% | 0.06% | +490.9% |
| Q1 2021 | $15,000 | – | 7,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 10,000 | $26,000 | 0.01% |
| PNC FINANCIAL SERVICES GROUP, INC. | 66 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 89,903 | $229,000 | 0.00% |
| DEUTSCHE BANK AG\ | 300 | $0 | 0.00% |
| MORGAN STANLEY | 1,910 | $5,000 | 0.00% |
| BlackRock Inc. | 669 | $2,000 | 0.00% |
| Citadel Advisors | 17,000 | $43,000 | 0.00% |
| Citadel Advisors | 10,298 | $26,000 | 0.00% |